Full Length Research Paper
References
|
Adnan AB, Ashour HM, Abdel Ghany YS, Bekhit Ael-D, Bakare A (2008). Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents. Eur. J. Med. Chem. 43:456-463 . |
|
|
Al-Nasiry S, Geusens N, Hanssens M, Luyten C, Pijnenborg R (2007). The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum. Reprod. 5:1304-1309. |
|
|
Bekhit AA, Haimanot T, Hymete A (2014) Evaluation of some 1H-pyrazole derivatives as a dual acting antimalarial and anti-leishmanial agents. Pak. J. Pharm. Sci. 27(6):1767-1773. |
|
|
Bernardino AM, Gomes AO, Charret KS, Freitas AC, Machado GM, Canto-Cavalheiro MM, Leon LL, Amaral VF (2006). Synthesis and leishmanicidal activities of 1-(4-X-phenyl)-N′-[(4-Y-phenyl)methylene]-1H-pyrazole-4-carbohydrazides. Eur. J. Med. Chem. 41:80-87. |
|
|
Braga FG, Coimbra ES, Magnum de OM, Lino CAM, Cancio MD, da Silver AD (2007). Synthesis and biological evaluation of some 6-substituted purines. Euro. J. Med. Chem. 42:530-537. |
|
|
Bucheton B, Kheir MM, El-Safi SH (2002). The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes. Infect. 4:1449-57. |
|
|
Cunico W, Cechinel CA, Bonacorso HG, Martins MA, Zanatta N, de Souza MV, Freitas IO, Soares RP, Krettli AU (2006). Antimalarial activity of 4-(5-trifluoromethyl-1H-pyrazol-1-yl)-chloroquine analogues. Bioorg. Med. Chem. Lett. 16:649-653. |
|
|
Daniele C, Alessandro De L, Marco R, Beatrice B, Fabrizio M, Matteo M, Sibilla S, Rita M, Lorenza C, Maurizio B (2008). Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis. Bioorg. Med. Chem. 16:8587-8591. |
|
|
Desjeux P (1996). Leishmaniasis: public health aspects and control. Clin. Dermatol. 14: 417-423. |
|
|
Desjeux P (1999). Global control and Leishmania-HIV co-infection. Clin. Dermatol. 17: 317-25 . |
|
|
dos Santos MS, Gomes AO, Bernardino AMR, de Souza MC, Khan MA, de Brito MA, Castro HC, Abreu PA, Rodrigues CR, de Léo RMM, Leon LL, Canto-Cavalheiro MM (2011). Synthesis and antileishmanial activity of new 1-Aryl-1H-Pyrazole-4-Carboximidamides derivatives. J. Braz. Chem. Soc. 22:352-358 |
|
|
Foroumadi A, Pournourmohammadi S, Soltani F, Asgharian-Rezaee M, Dabiri S, Kharazmi A, Shafiee A (2005). Synthesis and in vitro leishmanicidal activity of 2-(5-nitro-2-furyl) and 2-(5-nitro-2-thienyl)-5-substituted-1, 3, 4-thiadiazoles. Bioorg. Med. Chem. Lett. 15:1983-1985. |
|
|
Guiping O, Zhuo C, Xue-Jian C., Bao-An S, Pinaki SB, Song Y, Lin-Hong J, Wei X, De-Yu H, Song Z (2008). Synthesis and antiviral activity of novel pyrazole derivatives containing oxime esters group. Bioorg. Med. Chem. 16:9699-9707. |
|
|
Habtemariam S (2003). In vitro antileishaminial effects of antibacterial diterpenes from two Ethiopian premna species: P.schimperi and P. oligotricha. BMC pharmacol 3:1-6. |
|
|
Hai-Jun C, Yong L, Li-Na W, Qiang S, Jia L, Fa-Jun N, (2010). Discovery and structural optimization of pyrazole derivatives as novel inhibitors of Cdc25B. Bioorg. Med. Chem. Lett. 20:2876-2879. |
|
|
Katiyar SB, Srivastava K, Puri SK, Chauhan PM, (2005). Synthesis of 2-[3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents. Bioorg. Med. Chem. Lett. 15:4957-4960. |
|
|
Lingaiah N, Jhansi M, Hanmant KG, Rajashaker B, Rani MS, Prameela SNJ (2011). Subhashini, Synthesis and anti-inflammatory activity of some novel 3-phenyl-N-[3-(4-phenylpiperazin-1yl)propyl]-1H-pyrazole-5-carboxamide derivatives. Bioorg. Med. Chem. Lett. 21:4138-4140. |
|
|
Marco B, Monica RL, Giancarlo AS, Sylvie M, François T, Francesco M (2010). The synthesis and Angiotensin Converting Enzyme (ACE) inhibitory activity of chalcones and their pyrazole derivatives. Bioorg. Med. Chem. Lett. 20: 1990-1993. |
|
|
Marra RKF, Bernardino AMR, Proux TA, Charret KS, Lira MF, Castro HC, Souza AMT, Oliveira CD, Borges JC, Rodrigues CR, Canto-Cavalheiro MM, Leon LL, and Amaral VF (2012). 4-(1H-Pyrazol-1-yl) Benzenesulfonamide Derivatives: Identifying New Active Antileishmanial Structures for Use against a Neglected Disease. Molecules 17:12961-12973. |
|
|
Mohamed AZ, Abuo-Rahma GEA, Alaa AH, (2009). Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities. Eur. J. Med. Chem. 44:3480-3487. |
|
|
Mueller M, Ritmeijer K, Balasegaram M, Koummuki Y, Santana MR, Davidson R (2007). Unresponsiveness to AmBisome in some Sudanese patients with kala-azar. Trans. R. Soc. Trop. Med. Hyg. 101:19-24. |
|
|
Nakayama GR, Caton MC, Nova MP, Parandoosh Z (1997). Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J. Immunol. Methods. 204:205-208. |
|
|
Naresh S, Anu A, Sanjay BK, Nishi, Neena G, Suman G, Prem MS, Chauhan, (2006). Synthesis of 2,4,6-trisubstituted pyrimidine and triazine heterocycles as antileishmanial agents. Bioorg. Med. Chem.14:7706-7715. |
|
|
Nesrin G, Samiye Y, Esra K, Umut S, Ozgen O, Ucar G, Erdem Y, Engin K, YeÅŸilada A, Bilgina AA, (2007). A new therapeutic approach in Alzheimer disease: Some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics. Bioorg. Med. Chem. 15: 5775-5786. |
|
|
Nilesh JT, Manish PP (2011). Synthesis, characterization, and antimicrobial evaluation of carbostyril derivatives of 1H-pyrazole. Saudi Pharm. J. 19:75-83. |
|
|
Pinheiro LCS, Borges JC, dos Santos MS, Ferreira VF, Bernardino AMR, Tonioni R, Sathler PC, Castro HC, Santos DO, Nascimento SB, Bourguignon SC, Magalhães UO, Cabral L, Rodrigues CR (2012). Searching for new antileishmanial lead drug candidates: Synthesis, biological and theoretical evaluations of promising thieno[2,3-b] pyridine derivatives. J. Microbiol. Antimicrob. 4:32-39. |
|
|
Ramaiyan M, Ramaiyan V, Shanmugam M, Perumal Y, Dharmarajan S (2010). Pyrazole derivatives from azines of substituted phenacyl aryl/cyclohexyl sulfides and their antimycobacterial activity. Bioorg. Med. Chem. Lett. 20:6920-6924. |
|
|
Ramesh B, Chetan MB (2011). Novel dihydropyrimidines and its pyrazole derivatives: Synthesis and pharmacological screening. Eur. J. Med. Chem. 46:1882-1891. |
|
|
Reithinger R, Brooker S, Kolaczinski JH (2007). Visceral leishmaniasis in eastern Africa current status. Trans. R. Soc. Trop. Med. Hyg. 101: 1169-70. |
|
|
Sa’nchez-Moreno M, Go’mez-Contreras, Pilar Navarro F, Marı’n C, Ramı’rez-Macı’as I, Olmo F, Marı’a Sanz A, Campayo L, Cano C, Yunta MJR (2012). In vitro leishmanicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against Leishmania infantum and Leishmania braziliensis species. J. Antimicrob. Chemother. 67:387-397. |
|
|
Samir B, Wesam K, Ahmed AF (2011). Synthesis and antimicrobial activity of some new 4-hetarylpyrazole and furo[2,3-c]pyrazole derivatives. Eur. J. Med. Chem. 46:2555-2561 . |
|
|
Seifert K, Escobar P, Croft SL (2010). In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent. J. Antimicrob. Chemother. 3:508-11. |
|
|
Shimony O, Jaffe CL (2008). Rapid fluorescent assay for screening drugs on Leishmania amastigotes. J. Microb. Methods 75:196-200. |
|
|
Sundar S, Chakravarty J, Rai VK, Agrawal N, Singh SP, Chauhan V, Murray HW (2007). Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions. Clin. Infect. Dis. 45: 556-61. |
|
|
Tariku Y, Hymete A, Hailu A, Rohloff J (2010). Constituents, Antileishmanial Activity and Toxicity Profile of Volatile Oil from Berries of Croton macrostachyus. Nat. Prod. Commun. 5:975-980. |
|
|
Tuha A, Bekhit AA, Yimer S (2014). Synthesis and biological screening of some thienyl and phenyl pyrazoline derivatives as antimalarial agent. Thai. J. Pharm. Sci. 38(3):121-129. |
|
|
Vikramdeep M, Kamya G, Mario S, Manav M, Dhanji PR, Smita DR (2014). Synthesis and evaluation of new chalcones, derived pyrazoline and cyclohexenone derivatives as potent antimicrobial, antitubercular and antileishmanial agents. Med. Chem. Res. 23:2019-2032. |
|
|
Yang M, Arai C, Bakar Md A, Lu J, Ge JF, Pudhom K, Takasu K, Kasai K, Kaiser M, Brun R, Yardley V, Itoh I, Ihara M (2010). Fluorinated Rhodacyanine (SJL-01) Possessing High Efficacy for Visceral Leishmaniasis. J. Med. Chem. 53:368-373. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
